Julie Martin, MD
Obstetrics & Gynecology · Baton Rouge, LANPI 1679681753
Payments from drug & device makers
Across 99 payments — averaging $18.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mayne Pharma Commercial LLC$707
- AbbVie$200
- Exeltis, USA Inc.$131
- Therapeuticsmd, Inc.$130
- GSK$97
- Bayer$95
- plus $442 from 16 others
What the payments were for
- Food & beverage$1,803100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mayne Pharma Commercial LLC | 40 | $707 |
| AbbVie | 11 | $200 |
| Exeltis, USA Inc. | 8 | $131 |
| Therapeuticsmd, Inc. | 8 | $130 |
| GSK | 1 | $97 |
| Bayer | 5 | $95 |
| Minerva Surgical, Inc | 1 | $66 |
| Millicent US Inc | 3 | $53 |
| Coopersurgical, Inc. | 2 | $39 |
| Evofem Biosciences, Inc. | 5 | $37 |
| Organon | 2 | $36 |
| Amgen | 2 | $35 |
| Renovia Inc | 2 | $31 |
| Abbott | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Gilead | 1 | $18 |
| Pfizer | 1 | $16 |
| Novo Nordisk | 1 | $15 |
| Johnson & Johnson | 1 | $15 |
| Duchesnay USA Incorporated | 1 | $13 |
| Meditrina | 1 | $12 |
| Agile Therapeutics, Inc. | 1 | $12 |
How this compares
$1,803 in reported general payments places this provider in the 60th percentile of 608 obstetrics & gynecology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 44 | $2,834 |
| Estradiol (Once Weekly)Estradiol | 28 | $2,450 |
| Estradiol (Twice Weekly)Estradiol | 11 | $906 |
| Ibandronate Sodium | 14 | $184 |
| Medroxyprogesterone Acetate | 14 | $159 |
| Citalopram HbrCitalopram Hydrobromide | 13 | $20 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Baton Rouge
- Thomas PayneBaton Rouge$84K
- Joseph DiggsBaton Rouge$22K
- Taylar Childress-MckeithenBaton Rouge$9K
- Alison RodriguezNew Orleans$10.5M
- Scott StriplinCovington$6.1M
- Samuel AlexanderMetairie$2.6M
- Blake LandrySlidell$2M
- Clifton Nicholson-UhlMarrero$1.7M
- Brandon PerezMarrero$888K
- Earl PeeperNew Orleans$374K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.